Summary List Placement
We may still not know precisely how long immunity to the new coronavirus lasts, but researchers don’t think it’s forever.
“With human coronaviruses, you can get repeatedly infected — you’re not immune for life, you’re immune for some time,” Florian Krammer, a vaccinologist at the Icahn School of Medicine at Mount Sinai, told Business Insider.
“There’s no reason to think this coronavirus will behave differently,” he added.
That means that even after coronavirus vaccines become available and get widely distributed, we’ll likely need booster shots to stay protected over time.
“If immunity does turn out to be fleeting, we’ll need a plan of a vaccination plus a booster, or revaccination at periodic intervals,” Marm Kilpatrick, a disease ecologist, previously told Business Insider.
Two shots to start, then perhaps boosters, too
The two leading coronavirus vaccine candidates so far, from Moderna and Pfizer, both require two shots. Moderna’s two doses are administered a month apart, while Pfizer’s are given three weeks apart.
The more shots we need, however, the harder it is to ensure everyone gets them.
Plus, a two-dose vaccine regimen comes with supply-chain challenges: it requires twice as many vials, syringes, refrigerators, and clinic visits at a time when such resources are already limited.
But even after all those problems are mostly solved, a new challenge will arise: the need to figure out when our immunity fades, and if — or when — a booster shot is needed.
“Once we start seeing vaccine failures increasing, then we can consider booster doses,” Walt Orenstein, the former director of the US National Immunization Program, previously told Business Insider. He added, though, that “we don’t know at this stage whether that will be necessary.”
Some viruses, like hepatitis A or measles, are a one-and-done deal: Once you’re infected (or inoculated), you’re immune for life. But with coronaviruses, reinfection is possible after a period of months or years, according to the Mayo Clinic. That only happens to a fraction of people, though, and their second illness is usually mild.
Indeed, limited evidence suggests people could get reinfected with the new coronavirus. Some research has found that coronavirus antibodies decline after a period of months, which could mean our immunity might be similarly transient. Given that the efficacy of a vaccine hinges on its ability to prompt the body to generate antibodies, it’s therefore unlikely coronavirus shots will be a one-time affair.
But our …read more
Source:: Business Insider